[
  {
    "ts": null,
    "headline": "Supernus Pharmaceuticals Stock Scores RS Rating Upgrade",
    "summary": "A Relative Strength Rating upgrade for Supernus Pharmaceuticals shows improving technical performance.",
    "url": "https://finnhub.io/api/news?id=4195fe1641b91e154d5c9d3992815609ceef7ab538a23f13751456ef26364664",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754589611,
      "headline": "Supernus Pharmaceuticals Stock Scores RS Rating Upgrade",
      "id": 136268060,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "A Relative Strength Rating upgrade for Supernus Pharmaceuticals shows improving technical performance.",
      "url": "https://finnhub.io/api/news?id=4195fe1641b91e154d5c9d3992815609ceef7ab538a23f13751456ef26364664"
    }
  },
  {
    "ts": null,
    "headline": "Impressive Earnings May Not Tell The Whole Story For Incyte (NASDAQ:INCY)",
    "summary": "NasdaqGS:INCY 1 Year Share Price vs Fair Value Explore Incyte's Fair Values from the Community and select yours Incyte...",
    "url": "https://finnhub.io/api/news?id=08caa658a5c87141fc1dd42b309453f103dea74f24f86488e1c6c9ee2128e7ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754570568,
      "headline": "Impressive Earnings May Not Tell The Whole Story For Incyte (NASDAQ:INCY)",
      "id": 136246935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "NasdaqGS:INCY 1 Year Share Price vs Fair Value Explore Incyte's Fair Values from the Community and select yours Incyte...",
      "url": "https://finnhub.io/api/news?id=08caa658a5c87141fc1dd42b309453f103dea74f24f86488e1c6c9ee2128e7ca"
    }
  }
]